Birchview Capital, LP - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 2 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q3 2023$1,295,123
-29.0%
225,239
-90.0%
1.10%
-19.4%
Q2 2023$1,824,434
+115590.2%
2,252,3880.0%1.37%
+10.7%
Q1 2023$1,577
-0.8%
2,252,3880.0%1.24%
+10.0%
Q4 2022$1,590
-100.0%
2,252,3880.0%1.12%
-53.4%
Q3 2022$3,424,000
+53.1%
2,252,3880.0%2.41%
+48.3%
Q2 2022$2,236,000
-31.0%
2,252,3880.0%1.63%
-30.3%
Q1 2022$3,239,000
-72.4%
2,252,3880.0%2.33%
-69.2%
Q4 2021$11,732,000
-10.4%
2,252,3880.0%7.57%
-15.1%
Q3 2021$13,096,000
-27.1%
2,252,388
+0.9%
8.91%
-17.0%
Q2 2021$17,957,000
-2.3%
2,232,857
+0.9%
10.74%
-1.6%
Q1 2021$18,386,000
+10.6%
2,213,326
+0.9%
10.92%
+13.9%
Q4 2020$16,629,000
-64.4%
2,193,795
-50.0%
9.58%
-38.7%
Q3 2020$46,772,000
+40.6%
4,387,590
+100.0%
15.62%
-22.3%
Q2 2020$33,258,000
+82.0%
2,193,7950.0%20.10%
+24.0%
Q1 2020$18,274,000
-50.5%
2,193,795
+0.5%
16.21%
-39.6%
Q4 2019$36,906,000
-9.0%
2,183,7950.0%26.83%
-0.7%
Q3 2019$40,553,000
-18.8%
2,183,7950.0%27.02%
-11.1%
Q2 2019$49,965,000
+8.8%
2,183,7950.0%30.39%
+5.7%
Q1 2019$45,903,000
+82.8%
2,183,7950.0%28.76%
+21.1%
Q4 2018$25,114,000
-49.9%
2,183,7950.0%23.76%
-26.6%
Q3 2018$50,118,000
+2.9%
2,183,7950.0%32.35%
-2.3%
Q2 2018$48,699,000
-2.4%
2,183,7950.0%33.10%
+0.7%
Q1 2018$49,900,000
-12.8%
2,183,7950.0%32.86%
-2.0%
Q4 2017$57,215,000
+16.7%
2,183,7950.0%33.54%
+32.4%
Q3 2017$49,026,000
-17.9%
2,183,7950.0%25.32%
-19.8%
Q2 2017$59,727,000
+13.0%
2,183,7950.0%31.60%
+7.5%
Q1 2017$52,848,000
+17.1%
2,183,795
+0.4%
29.39%
+5.8%
Q4 2016$45,148,000
-23.9%
2,175,7950.0%27.78%
-19.7%
Q3 2016$59,312,000
+89.4%
2,175,7950.0%34.62%
+52.3%
Q2 2016$31,310,000
+0.1%
2,175,7950.0%22.73%
+2.0%
Q1 2016$31,266,000
-32.5%
2,175,795
+0.9%
22.29%
-16.4%
Q4 2015$46,328,000
+38.5%
2,155,795
+4.3%
26.68%
+23.9%
Q3 2015$33,453,000
-37.3%
2,067,5600.0%21.53%
-23.6%
Q2 2015$53,364,000
+14.7%
2,067,5600.0%28.19%
+15.4%
Q1 2015$46,520,000
+17.4%
2,067,560
+0.1%
24.44%
+6.2%
Q4 2014$39,638,0002,065,56023.01%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders